VYPR
Medium severity6.5NVD Advisory· Published Jan 20, 2026· Updated Jun 17, 2026

CVE-2026-21923

CVE-2026-21923

Description

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Designer accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).

Affected products

3
  • cpe:2.3:a:oracle:life_sciences_central_designer:7.0.1.0:*:*:*:*:*:*:*+ 2 more
    • cpe:2.3:a:oracle:life_sciences_central_designer:7.0.1.0:*:*:*:*:*:*:*
    • (no CPE)range: 7.0.1.0
    • (no CPE)range: = 7.0.1.0

Patches

Vulnerability mechanics

References

1

News mentions

0

No linked articles in our index yet.